U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
dezamizumab [INN]
Preferred Name English
DEZAMIZUMAB
INN   WHO-DD  
USAN   INN  
Official Name English
GSK-2398852
Code English
IMMUNOGLOBULIN G1, ANTI-(SERUM AMYLOID P PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL GSK2398852 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK2398852 LIGHT CHAIN, DIMER
Systematic Name English
DEZAMIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APCS (AMYLOID P COMPONENT SERUM, SERUM AMYLOID P COMPONENT, SAP, PENTRAXIN-2, PTX2)), HUMANIZED MONOCLONAL ANTIBODY
Systematic Name English
ANTI - SAP MAB
Common Name English
GSK2398852
Code English
Dezamizumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
FDA ORPHAN DRUG 462714
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
Code System Code Type Description
CAS
1662664-56-3
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
INN
10364
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
DRUG BANK
DB15153
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
NCI_THESAURUS
C153210
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
FDA UNII
6U3F28IT58
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
SMS_ID
100000174640
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
USAN
FG-81
Created by admin on Tue Apr 01 16:41:31 GMT 2025 , Edited by admin on Tue Apr 01 16:41:31 GMT 2025
PRIMARY
ACTIVE MOIETY
DEZAMIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966